Skip to main content
Erschienen in: Quality of Life Research 10/2013

01.12.2013

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

verfasst von: Ellen M. Lavoie Smith, Debra L. Barton, Rui Qin, Preston D. Steen, Neil K. Aaronson, Charles L. Loprinzi

Erschienen in: Quality of Life Research | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This clinimetric analysis was conducted to evaluate the reliability, validity, and responsiveness to changeover time of the QLQ-CIPN20 when used to quantify patient-reported chemotherapy-induced peripheral neuropathy (CIPN).

Methods

Participants recruited to four cooperative group trials were pooled to create two groups (n = 376, 575): those who did versus did not receive neurotoxic chemotherapy. QLQ-CIPN20 internal consistency reliability was assessed using Cronbach’s alpha coefficients. Instrument validity was assessed using factor analysis, by evaluating score correlations with other CIPN and pain measures, and by comparing scores between contrasting groups. Cohen’s d was used to assess responsiveness to change.

Results

Alpha coefficients for the sensory, motor, and autonomic scales were 0.88, 0.88, and 0.78, respectively. However, autonomic scale and hearing loss items exhibited low item–item correlations (r ≤ 0.30) and thus were deleted. Moderate correlations were found between QLQ-CIPN20 and Brief Pain Inventory pain severity items (r 0.30–0.57, p ≤ .0001). Correlation between the QLQ-CIPN20 sensory and toxicity grading scale scores was low (r = .20; p ≤ .01). Mean scores were higher (worse) (p ≤ 0.0001) in individuals who did versus did not receive neurotoxic chemotherapy. The sensory and motor scales exhibited moderate-high responsiveness to change (Cohen’s d = 0.82 and 0.48, respectively). Factor analysis indicated that the 16-item version formed distinct factors for lower and upper extremity CIPN, delineating typical distal to proximal CIPN progression.

Conclusions

Results provide support for QLQ-CIPN20 sensory and motor scale reliability and validity. The more parsimonious and clinically relevant 16-item version merits further consideration.
Literatur
1.
Zurück zum Zitat Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006). Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Seminars in Oncology, 33(1), 15–49.PubMedCrossRef Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006). Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Seminars in Oncology, 33(1), 15–49.PubMedCrossRef
2.
Zurück zum Zitat Argyriou, A. A., Bruna, J., Marmiroli, P., & Cavaletti, G. (2012). Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Critical Reviews in Oncology-Hematology, 82(1), 51–77.CrossRef Argyriou, A. A., Bruna, J., Marmiroli, P., & Cavaletti, G. (2012). Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Critical Reviews in Oncology-Hematology, 82(1), 51–77.CrossRef
3.
Zurück zum Zitat Stubblefield, M. D., Burstein, H. J., Burton, A. W., Custodio, C. M., Deng, G. E., Ho, M., et al. (2009). NCCN task force report: Management of neuropathy in cancer. Journal of the National Comprehensive Cancer Network, 7(Suppl 5), S1–S26.PubMed Stubblefield, M. D., Burstein, H. J., Burton, A. W., Custodio, C. M., Deng, G. E., Ho, M., et al. (2009). NCCN task force report: Management of neuropathy in cancer. Journal of the National Comprehensive Cancer Network, 7(Suppl 5), S1–S26.PubMed
4.
Zurück zum Zitat Argyriou, A. A., Zolota, V., Kyriakopoulou, O., & Kalofonos, H. P. (2010). Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents. Journal of B.U.On, 15(3), 435–446. Argyriou, A. A., Zolota, V., Kyriakopoulou, O., & Kalofonos, H. P. (2010). Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents. Journal of B.U.On, 15(3), 435–446.
5.
Zurück zum Zitat Paice, J. A. (2009). Clinical challenges: Chemotherapy-induced peripheral neuropathy. Seminars in Oncology Nursing, 25(2 Suppl 1), S8–S19.PubMedCrossRef Paice, J. A. (2009). Clinical challenges: Chemotherapy-induced peripheral neuropathy. Seminars in Oncology Nursing, 25(2 Suppl 1), S8–S19.PubMedCrossRef
6.
Zurück zum Zitat Loprinzi, C. L., Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., et al. (2011). Natural history of paclitaxel-associated acute pain syndrome: Prospective cohort study NCCTG N08C1. Journal of Clinical Oncology, 29(11), 1472–1478.PubMedCrossRef Loprinzi, C. L., Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., et al. (2011). Natural history of paclitaxel-associated acute pain syndrome: Prospective cohort study NCCTG N08C1. Journal of Clinical Oncology, 29(11), 1472–1478.PubMedCrossRef
7.
Zurück zum Zitat Visovsky, C., & Daly, B. J. (2004). Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy. Journal of the American Academy of Nurse Practitioners, 16(8), 353–359.PubMedCrossRef Visovsky, C., & Daly, B. J. (2004). Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy. Journal of the American Academy of Nurse Practitioners, 16(8), 353–359.PubMedCrossRef
8.
Zurück zum Zitat Wampler, M. A., Miaskowski, C., Hamel, K., Byl, N., Rugo, H., & Topp, L. S. (2006). The modified total neuropathy score: A clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer. Supportive Oncology, 4(8), W9–W16. Wampler, M. A., Miaskowski, C., Hamel, K., Byl, N., Rugo, H., & Topp, L. S. (2006). The modified total neuropathy score: A clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer. Supportive Oncology, 4(8), W9–W16.
9.
Zurück zum Zitat Bakitas, M. A. (2007). Background noise: The experience of chemotherapy-induced peripheral neuropathy. Nursing Research, 56(5), 323–331.PubMedCrossRef Bakitas, M. A. (2007). Background noise: The experience of chemotherapy-induced peripheral neuropathy. Nursing Research, 56(5), 323–331.PubMedCrossRef
10.
Zurück zum Zitat Smith, E. M. L., Bakitas, M. A., Homel, P., Piehl, M., Kingman, L., Fadul, C. E., et al. (2011). Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer. Journal of Pain and Symptom Management, 42(6), 822–838.PubMedCrossRef Smith, E. M. L., Bakitas, M. A., Homel, P., Piehl, M., Kingman, L., Fadul, C. E., et al. (2011). Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer. Journal of Pain and Symptom Management, 42(6), 822–838.PubMedCrossRef
11.
Zurück zum Zitat Griffith, K., Merkies, I. S. J., Hill, E., & Cornblath, D. (2010). Measures of chemotherapy-induced peripheral neuropathy: A systematic review of psychometric properties. Journal of the Peripheral Nervous System, 15(4), 314–325.PubMedCrossRef Griffith, K., Merkies, I. S. J., Hill, E., & Cornblath, D. (2010). Measures of chemotherapy-induced peripheral neuropathy: A systematic review of psychometric properties. Journal of the Peripheral Nervous System, 15(4), 314–325.PubMedCrossRef
12.
Zurück zum Zitat Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., et al. (2010). Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools. European Journal of Cancer, 46(3), 479–494.PubMedCrossRef Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., et al. (2010). Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools. European Journal of Cancer, 46(3), 479–494.PubMedCrossRef
13.
Zurück zum Zitat Postma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., et al. (2005). The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer, 41(8), 1135–1139.PubMedCrossRef Postma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., et al. (2005). The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer, 41(8), 1135–1139.PubMedCrossRef
14.
Zurück zum Zitat Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: Global use of the brief pain inventory. Annals of the Academy of Medicine, Singapore, 23(2), 129.PubMed Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: Global use of the brief pain inventory. Annals of the Academy of Medicine, Singapore, 23(2), 129.PubMed
16.
Zurück zum Zitat Barton, D. L., Wos, E. J., Qin, R., Mattar, B. I., Green, N. B., Lanier, K. S., et al. (2011). A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Supportive care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 19(6), 833–841.CrossRef Barton, D. L., Wos, E. J., Qin, R., Mattar, B. I., Green, N. B., Lanier, K. S., et al. (2011). A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Supportive care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 19(6), 833–841.CrossRef
17.
Zurück zum Zitat Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A., et al. (2012). Further data supporting that the paclitaxel-associated acute pain syndrome is associated with the development of peripheral neuropathy: NCCTG Trial N08C1. Cancer, 118(20), 5171–5178. Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A., et al. (2012). Further data supporting that the paclitaxel-associated acute pain syndrome is associated with the development of peripheral neuropathy: NCCTG Trial N08C1. Cancer, 118(20), 5171–5178.
18.
Zurück zum Zitat Ferketich, S. (1991). Focus on psychometrics: Aspects of item analysis. Research in Nursing & Health, 14(2), 165–168.CrossRef Ferketich, S. (1991). Focus on psychometrics: Aspects of item analysis. Research in Nursing & Health, 14(2), 165–168.CrossRef
19.
Zurück zum Zitat Boehmer, S., & Luszczynska, A. (2006). Two kinds of items in quality of life instruments: ‘Indicator and causal variables’ in the EORTC qlq-c30. Quality of Life Research, 15(1), 131–141.PubMedCrossRef Boehmer, S., & Luszczynska, A. (2006). Two kinds of items in quality of life instruments: ‘Indicator and causal variables’ in the EORTC qlq-c30. Quality of Life Research, 15(1), 131–141.PubMedCrossRef
20.
Zurück zum Zitat Fayers, P. M. (2004). Quality-of-life measurement in clinical trials—the impact of causal variables. Journal of Biopharmaceutical Statistics, 14(1), 155–176.PubMedCrossRef Fayers, P. M. (2004). Quality-of-life measurement in clinical trials—the impact of causal variables. Journal of Biopharmaceutical Statistics, 14(1), 155–176.PubMedCrossRef
21.
Zurück zum Zitat Pett, M. A., Lackey, N. R., & Sullivan, J. L. (2003). Making sense of factor analysis: The use of factor analysis for instrument development in health care research. Thousand Oaks: Sage Publications. Pett, M. A., Lackey, N. R., & Sullivan, J. L. (2003). Making sense of factor analysis: The use of factor analysis for instrument development in health care research. Thousand Oaks: Sage Publications.
22.
Zurück zum Zitat Barrett, P. P. (2007). Structural equation modeling: Adjudging model fit. Personality and Individual Differences, 42(5), 815–824.CrossRef Barrett, P. P. (2007). Structural equation modeling: Adjudging model fit. Personality and Individual Differences, 42(5), 815–824.CrossRef
23.
Zurück zum Zitat Flora, D. D. B. (2004). An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychological Methods, 9(4), 466–491.PubMedCrossRef Flora, D. D. B. (2004). An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychological Methods, 9(4), 466–491.PubMedCrossRef
24.
Zurück zum Zitat Hayduk, L. L. (2007). Testing! testing! one, two, three—Testing the theory in structural equation models! Personality and Individual Differences, 42(5), 841–850.CrossRef Hayduk, L. L. (2007). Testing! testing! one, two, three—Testing the theory in structural equation models! Personality and Individual Differences, 42(5), 841–850.CrossRef
25.
Zurück zum Zitat Beauducel, A. A. (2005). Simulation study on fit indexes in CFA based on data with slightly distorted simple structure. Structural Equation Modeling, 12(1), 41–75.CrossRef Beauducel, A. A. (2005). Simulation study on fit indexes in CFA based on data with slightly distorted simple structure. Structural Equation Modeling, 12(1), 41–75.CrossRef
26.
Zurück zum Zitat Fan, X. X. (2005). Sensitivity of fit indexes to misspecified structural or measurement model components: Rationale of two-index strategy revisited. Structural Equation Modeling, 12(3), 343–367.CrossRef Fan, X. X. (2005). Sensitivity of fit indexes to misspecified structural or measurement model components: Rationale of two-index strategy revisited. Structural Equation Modeling, 12(3), 343–367.CrossRef
27.
Zurück zum Zitat Basch, E., Jia, X., Heller, G., Barz, A., Sit, L., Fruscione, M., et al. (2009). Adverse symptom event reporting by patients vs clinicians: Relationships With clinical outcomes. Journal of the National Cancer Institute, 101(23), 1624–1632.PubMedCrossRef Basch, E., Jia, X., Heller, G., Barz, A., Sit, L., Fruscione, M., et al. (2009). Adverse symptom event reporting by patients vs clinicians: Relationships With clinical outcomes. Journal of the National Cancer Institute, 101(23), 1624–1632.PubMedCrossRef
28.
Zurück zum Zitat Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey: Lawrence Earlbaum and Associate. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, New Jersey: Lawrence Earlbaum and Associate.
29.
Zurück zum Zitat Clayton, M. F., & Pett, M. A. (2011). Modeling relationships in clinical research using path analysis Part II: Evaluating the model. Journal for Specialists in Pediatric Nursing: JSPN, 16(1), 75–79.PubMedCrossRef Clayton, M. F., & Pett, M. A. (2011). Modeling relationships in clinical research using path analysis Part II: Evaluating the model. Journal for Specialists in Pediatric Nursing: JSPN, 16(1), 75–79.PubMedCrossRef
30.
Zurück zum Zitat Hu, L. L. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1–55.CrossRef Hu, L. L. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1–55.CrossRef
31.
Zurück zum Zitat Zheng, Z. E. (2010). Research note–toward a causal interpretation from observational data: A new bayesian networks method for structural models with latent variables. Information Systems Research, 21(2), 365–391.CrossRef Zheng, Z. E. (2010). Research note–toward a causal interpretation from observational data: A new bayesian networks method for structural models with latent variables. Information Systems Research, 21(2), 365–391.CrossRef
32.
Zurück zum Zitat Spirtes, P., Glymour, C., Scheines, R., & Tillman, R. (2010). Automated search for causal relations: Theory and practice. In R. Dechter, H. Geffner, & J. Y. Halpern (Eds.), Heuristics, probability, and causality: A tribute to judea pearl (pp. 467–506). London, UK: College Publications. Spirtes, P., Glymour, C., Scheines, R., & Tillman, R. (2010). Automated search for causal relations: Theory and practice. In R. Dechter, H. Geffner, & J. Y. Halpern (Eds.), Heuristics, probability, and causality: A tribute to judea pearl (pp. 467–506). London, UK: College Publications.
Metadaten
Titel
Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
verfasst von
Ellen M. Lavoie Smith
Debra L. Barton
Rui Qin
Preston D. Steen
Neil K. Aaronson
Charles L. Loprinzi
Publikationsdatum
01.12.2013
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 10/2013
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0379-8

Weitere Artikel der Ausgabe 10/2013

Quality of Life Research 10/2013 Zur Ausgabe